Faculty & Scientific Staff
Background
Dr. DeBerg completed her PhD in physics at the University of Illinois at Urbana Champaign, using single-molecule fluorescence microscopy approaches to study motor proteins. Following her PhD, Hannah moved to Seattle and completed a postdoc at the University of Washington in the chemistry and biophysics departments. She joined BRI in 2015 as a bioinformatician in Peter Linsley’s laboratory where she became fascinated by the immune system.
Area of Research
Dr. DeBerg currently serves as the Bioinformatics Group Manager where she continues to enjoy working at the intersection of immunology, big data and advanced analysis.
Featured Publications
Sep 2023
Proinflammatory islet antigen reactive CD4 T cells are linked with response to alefacept in type 1 diabetes.
JCI Insight
Balmas E, Chen J, Hu AK, DeBerg HA, Rosasco MG, Gersuk VH, Serti E, Speake C, Greenbaum CJ, Nepom GT, Linsley PS, Cerosaletti K
May 2022
Prioritization of autoimmune disease-associated genetic variants that perturb regulatory element activity in T cells.
Nat Genet
Mouri K, Guo MH, de Boer CG, Lissner MM, Harten IA, Newby GA, DeBerg HA, Platt WF, Gentili M, Liu DR, Campbell DJ, Hacohen N, Tewhey R, Ray JP
Mar 2022
Oral desensitization therapy for peanut allergy induces dynamic changes in peanut-specific immune responses.
Allergy
Bajzik V, DeBerg HA, Garabatos N, Rust BJ, Obrien KK, Nguyen QA, O'Rourke C, Smith A, Walker AH, Quinn C, Gersuk VH, Farrington M, Jeong D, Vickery BP, Adelman DC, Wambre E
Mar 2022
MAdCAM-1 Costimulates T Cells through Integrin α(4)β(7) to Cause Gene Expression Events Resembling Costimulation through CD28.
Immunohorizons
DeBerg HA, Konecny AJ, Shows DM, Lord JD
Nov 2021
Autoreactive T cell receptors with shared germline-like α chains in type 1 diabetes.
JCI Insight
Linsley PS, Barahmand-Pour-Whitman F, Balmas E, DeBerg HA, Flynn KJ, Hu AK, Rosasco MG, Chen J, O'Rourke C, Serti E, Gersuk VH, Motwani K, Seay HR, Brusko TM, Kwok WW, Speake C, Greenbaum CJ, Nepom GT, Cerosaletti K
